- •A novel constant-current DBS device for patients with essential tremor.
- •A prospective, controlled, multicenter study confirms the efficacy of thalamic DBS.
- •Constant-current DBS may offer advantages over constant voltage devices.
This study of thalamic deep brain stimulation (DBS) investigated whether a novel constant-current device improves tremor and activities of daily living (ADL) in patients with essential tremor (ET).
A prospective, controlled, multicenter study was conducted at 12 academic centers. We investigated the safety and efficacy of unilateral and bilateral constant-current DBS of the ventralis intermedius (VIM) nucleus of the thalamus in patients with essential tremor whose tremor was inadequately controlled by medications. The primary outcome measure was a rater-blinded assessment of the change in the target limb tremor score in the stimulation-on versus stimulation-off state six months following surgery. Multiple secondary outcomes were assessed at one-year follow-up, including motor, mood, and quality-of-life measures.
127 patients were implanted with VIM DBS. The blinded, primary outcome variable (n = 76) revealed a mean improvement of 1.25 ± 1.26 points in the target limb tremor rating scale (TRS) score in the arm contralateral to DBS (p < 0.001). Secondary outcome variables at one year revealed significant improvements (p ≤ 0.001) in quality of life, depression symptoms, and ADL scores. Forty-seven patients had a second contralateral VIM-DBS, and this group demonstrated reduction in second-sided tremor at 180 days (p < 0.001). Serious adverse events related to the surgery included infection (n = 3), intracranial hemorrhage (n = 3), and device explantation (n = 3).
Unilateral and bilateral constant-current VIM DBS significantly improves upper extremity tremor, ADL, quality of life, and depression in patients with severe ET.
To read this article in full you will need to make a payment
Purchase one-time access:Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
One-time access price info
- For academic or personal research use, select 'Academic and Personal'
- For corporate R&D use, select 'Corporate R&D Professionals'
Subscribe:Subscribe to Parkinsonism & Related Disorders
Already a print subscriber? Claim online access
Already an online subscriber? Sign in
Register: Create an account
Institutional Access: Sign in to ScienceDirect
- The impact of thalamic stimulation on activities of daily living for essential tremor.Surg. Neurol. 2003; 59 (479-484; discussion 484–475)
- Unilateral thalamic deep brain stimulation for refractory essential tremor and Parkinson's disease tremor.Neurology. 1998; 51: 1063-1069
- Multicentre European study of thalamic stimulation in parkinsonian and essential tremor.J. Neurol. Neurosurg. Psychiatry. 1999; 66: 289-296
- Thalamic stimulation for the treatment of midline tremors in essential tremor patients.Neurology. 2000; 54: 2342-2344
- Clinical rating scale for tremor.in: Jankovic J T.E. Parkinson's Disease and Movement Disorders. Urban and Schwarzenberg, Munich1993: 271-280
- Long-term follow-up of thalamic deep brain stimulation for essential tremor - patient satisfaction and mortality.BMC Neurol. 2014; 14: 120
- Bilateral thalamic deep brain stimulation: midline tremor control.J. Neurol. Neurosurg. Psychiatry. 2005; 76: 684-690
- Thalamic deep brain stimulation for essential tremor: recommendations for long-term outcome analysis.Can. J. Neurol. Sci. 2004; 31: 333-342
- Unilateral thalamic deep brain stimulation in essential tremor demonstrates long-term ipsilateral effects.Park. Relat. Disord. 2013; 19: 1113-1117
- A comparison of continuous thalamic stimulation and thalamotomy for suppression of severe tremor.N. Engl. J. Med. 2000; 342: 461-468
- Bilateral thalamic stimulation for the treatment of essential tremor.Neurology. 1999; 53: 1447-1450
- High-frequency unilateral thalamic stimulation in the treatment of essential and parkinsonian tremor.Ann. Neurol. 1997; 42: 292-299
- Practice parameter: therapies for essential tremor: report of the quality standards subcommittee of the American Academy of Neurology.Neurology. 2005; 64: 2008-2020
- Deep brain stimulation for essential tremor: a systematic review.Mov. Disord. 2010; 25: 1550-1559
- Subthalamic deep brain stimulation with a constant-current device in Parkinson's disease: an open-label randomised controlled trial.Lancet Neurol. 2012; 11: 140-149
- Current-controlled deep brain stimulation reduces in vivo voltage fluctuations observed during voltage-controlled stimulation.Clin. Neurophysiol. 2010; 121: 2128-2133
- Quality of life in Essential Tremor Questionnaire (QUEST): development and initial validation.Park. Relat. Disord. 2005; 11: 367-373
- Summary of Safety and Effectiveness Document for Medtronic Activa Tremor Control System.2002(Accessed 5 November 2004)
- Risks of common complications in deep brain stimulation surgery: management and avoidance.J. Neurosurg. 2014; 120: 132-139
- The safety and efficacy of thalamic deep brain stimulation in essential tremor: 10 years and beyond.J. Neurol. Neurosurg. Psychiatry. 2014; 85: 567-572
- Deep brain stimulation hardware complications in patients with movement disorders: risk factors and clinical correlations.Stereotact. Funct. Neurosurg. 2012; 90: 300-306
- Multicentre European study of thalamic stimulation in essential tremor: a six year follow up.J. Neurol. Neurosurg. Psychiatry. 2003; 74: 1387-1391
- Long-term evaluation of deep brain stimulation of the thalamus.J. Neurosurg. 2006; 104: 506-512
- Long-term efficacy of thalamic deep brain stimulation for tremor: double-blind assessments.Mov. Disord. 2003; 18: 163-170
- Postural tremor suppression is dependent on thalamic stimulation frequency.Mov. Disord. 2006; 21: 1290-1292
- Combined (thalamotomy and stimulation) stereotactic surgery of the VIM thalamic nucleus for bilateral Parkinson disease.Appl. Neurophysiol. 1987; 50: 344-346
- The rationale driving the evolution of deep brain stimulation to constant-current devices.Neuromodulation. 2015; 18 (85-88; discussion): 88-89
Published online: March 29, 2017
Accepted: March 28, 2017
Received in revised form: March 10, 2017
Received: January 6, 2017
☆Mayo Clinic does not endorse specific products or services included in this article.
© 2017 Elsevier Ltd. All rights reserved.